Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.

@article{Willows2018EarlyEO,
  title={Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.},
  author={Karla Willows and Songul Bozat-Emre and Christiaan H. Righolt and Erich V. Kliewer and Salaheddin M. Mahmud},
  journal={Sexually transmitted diseases},
  year={2018},
  volume={45 4},
  pages={254-259}
}
BACKGROUND We assessed the effectiveness of the quadrivalent human papillomavirus vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital warts (AGWs) and to what extent effectiveness depends on age at vaccination and number of doses. METHODS Female participants 9 years or older who received the qHPV in Manitoba between… CONTINUE READING